APAC Automated Cell Cultures Market - Industry Trends and Forecast to 2029

TABLE OF CONTENTS

1 INTRODUCTION 36

• 1.1 OBJECTIVES OF THE STUDY 36
• 1.2 MARKET DEFINITION 36
• 1.3 OVERVIEW 36
• 1.4 LIMITATIONS 38
• 1.5 MARKETS COVERED 38

2 MARKET SEGMENTATION 41

• 2.1 MARKETS COVERED 41
• 2.2 GEOGRAPHICAL SCOPE 42
• 2.3 YEARS CONSIDERED FOR THE STUDY 43
• 2.4 CURRENCY AND PRICING 43
• 2.5 DBMR TRIPOD DATA VALIDATION MODEL 44
• 2.6 MULTIVARIATE MODELLING 47
• 2.7 PRODUCT TYPE LIFELINE CURVE 47
• 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 48
• 2.9 DBMR MARKET POSITION GRID 49
• 2.10 MARKET APPLICATION COVERAGE GRID 50
• 2.11 VENDOR SHARE ANALYSIS 51
• 2.12 SECONDARY SOURCES 52
• 2.13 ASSUMPTIONS 52

3 EXECUTIVE SUMMARY 53

4 PREMIUM INSIGHTS 55

5 REGULATORY FRAMEWORK FOR ASIA PACIFIC AUTOMATED CELL CULTURES MARKET 56

6 MARKET OVERVIEW 58

• 6.1 DRIVERS 60
  • 6.1.1 INCREASING DEMAND FOR CELL CULTURE TECHNOLOGY IN VACCINE PRODUCTION 60
  • 6.1.2 TECHNOLOGICAL ADVANCEMENTS IN CELL CULTURE TECHNOLOGY SYSTEMS 60
  • 6.1.3 WIDE ACCEPTANCE OF CELL CULTURE TECHNIQUES IN VARIOUS APPLICATIONS 60
  • 6.1.4 GROWING BIOTECHNOLOGY SECTOR, ALONG WITH RISING HEALTHCARE EXPENDITURE 61
  • 6.1.5 ADVANTAGES OF AUTOMATED CELL CULTURE SYSTEMS OVER MANUAL METHODS 61
• 6.2 RESTRAINTS 62
  • 6.2.1 HIGH COST OF AUTOMATED CELL CULTURE SYSTEMS 62
  • 6.2.2 LIMITATIONS ASSOCIATED WITH AUTOMATED CELL CULTURES 62
  • 6.2.3 MAINTENANCE AND UPDATING OF EQUIPMENT 63
  • 6.2.4 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 63
• 6.3 OPPORTUNITIES 64
  • 6.3.1 NEW PRODUCT LAUNCHES AND TECHNOLOGY DEVELOPMENTS 64
  • 6.3.2 INCREASING COLLABORATION AMONG MARKET PLAYERS 64
  • 6.3.3 INCREASING OUTSOURCING FACILITIES 65
  • 6.3.4 INCREASE IN DEMAND FOR 3D CELL CULTURE 65
• 6.4 CHALLENGES 66
  • 6.4.1 DEVELOPMENT AND MAINTENANCE OF EXPERTISE 66
  • 6.4.2 LACK OF INFRASTRUCTURE FOR CELL-BASED RESEARCH IN EMERGING ECONOMIES 66

7 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET, BY PRODUCT 68

• 7.1 OVERVIEW 69
• 7.2 CONSUMABLES 72
  • 7.2.1 MEDIA 72
    • 7.2.1.1 SERUM FREE MEDIA 73
    • 7.2.1.2 CLASSICAL MEDIA & SALTS 73
    • 7.2.1.3 STEM CELL CULTURE MEDIA 73
    • 7.2.1.4 SPECIALTY MEDIA 73
  • 7.2.2 BUFFERS AND SUPPLEMENTS 73
    • 7.2.2.1 PLASMA 74
    • 7.2.2.2 SERA 74
    • 7.2.2.3 FETAL BOVINE SERA 74
    • 7.2.2.4 ADULT BOVINE SERA 74
    • 7.2.2.5 OTHERS ANIMAL SERA 74
  • 7.2.3 REAGENTS 74
    • 7.2.3.1 SUPPLEMENTS & GROWTH FACTORS 75
    • 7.2.3.2 BUFFERS & CHEMICALS 75
    • 7.2.3.3 CELL DISASSOCIATION REAGENTS 75
    • 7.2.3.4 BALANCED SALT SOLUTIONS 75
    • 7.2.3.5 ATTACHMENT & MATRIX FACTORS 75
    • 7.2.3.6 ANTIBIOTICS/ANTIMYCOTICS 75
    • 7.2.3.7 CONTAMINATION DETECTION KITS 76
    • 7.2.3.8 CRYOPROTECTIVE REAGENTS 76
    • 7.2.3.9 OTHERS CELL CULTURE REAGENTS 76
  • 7.2.4 ACCESSORIES 76
• 7.3 INSTRUMENTS 76
  • 7.3.1 SUPPORTING EQUIPMENTS 77
    • 7.3.1.1 CELL COUNTERS 77
    • 7.3.1.2 IMAGE BASED CELL COUNTERS 77
    • 7.3.1.3 FLOW CYTOMETERS 78
    • 7.3.1.4 COULTER COUNTERS 78
    • 7.3.1.5 CELL EXPANSION 78
    • 7.3.1.6 LIQUID HANDLERS 78
    • 7.3.1.7 OTHERS 78
  • 7.3.2 BIOREACTORS 78
    • 7.3.2.1 SINGLE USE BIOREACTORS 78
    • 7.3.2.2 CONVENTIONAL BIOREACTORS 79
    • 7.3.2.3 OTHERS 79
  • 7.3.3 STORAGE EQUIPMENTS 79
    • 7.3.3.1 REFRIGERATORS & FREEZERS 79
    • 7.3.3.2 CRYOSTORAGE SYSTEMS 79
    • 7.3.3.3 OTHERS 79

8 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET, BY TYPE 80

• 8.1 OVERVIEW 81
• 8.2 INFINITE CELL LINE CULTURES 84
• 8.3 FINITE CELL LINE CULTURES 84

9 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET, BY APPLICATION 85

• 9.1 OVERVIEW 86
• 9.2 DRUG DEVELOPMENT 89
• 9.3 STEM CELL RESEARCH 89
  • 9.3.1 EMBRYONIC STEM CELLS 90
  • 9.3.2 TISSUE-SPECIFIC STEM CELLS 90
  • 9.3.3 MESENCHYMAL STEM CELLS 90
  • 9.3.4 INDUCED PLURIPOTENT STEM CELLS 90
• 9.4 REGENERATIVE MEDICINE 90
  • 9.4.1 STEM CELL THERAPY 91
  • 9.4.2 PLATELET-RICH PLASMA THERAPY (OR PRP INJECTIONS) 91
  • 9.4.3 TISSUE ENGINEERING 91
  • 9.4.4 AMNIOTIC-MEMBRANE DERIVED STEM CELLS 91
• 9.5 CANCER RESEARCH 92
• 9.6 VACCINES 92
• 9.7 OTHERS 93

10 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET, BY END USER 94

• 10.1 OVERVIEW 95
• 10.2 BIOTECH COMPANIES 98
• 10.3 RESEARCH ORGANIZATIONS 98
• 10.4 ACADEMIC RESEARCH INSTITUTES 98
• 10.5 OTHERS 99

11 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET, BY REGION 100

• 11.1 ASIA-PACIFIC 101
  • 11.1.1 CHINA 110
  • 11.1.2 JAPAN 115
  • 11.1.3 SOUTH KOREA 120
  • 11.1.4 INDIA 125
  • 11.1.5 AUSTRALIA 130
  • 11.1.6 SINGAPORE 135
  • 11.1.7 THAILAND 140
  • 11.1.8 MALAYSIA 145
  • 11.1.9 INDONESIA 150
  • 11.1.10 PHILIPPINES 155
  • 11.1.11 REST OF ASIA-PACIFIC 160

12 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: COMPANY LANDSCAPE 161

• 12.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 161

13 COMPANY PROFILE 162

• 13.1 LONZA 162
  • 13.1.1 COMPANY SNAPSHOT 162
  • 13.1.2 REVENUE ANALYSIS 162
  • 13.1.3 COMPANY SHARE ANALYSIS 163
  • 13.1.4 PRODUCT PORTFOLIO 163
  • 13.1.5 RECENT DEVELOPMENTS 164
  • 13.1.6 SWOT ANALYSIS 165
• 13.2 MERCK KGAA 166
  • 13.2.1 COMPANY SNAPSHOT 166
  • 13.2.2 RECENT FINANCIALS 166
  • 13.2.3 COMPANY SHARE ANALYSIS 167
  • 13.2.4 PRODUCT PORTFOLIO 167
  • 13.2.5 RECENT DEVELOPMENTS 167
  • 13.2.6 SWOT ANALYSIS 168
• 13.3 THERMO FISHER SCIENTIFIC INC. 169
  • 13.3.1 COMPANY SNAPSHOT 169
  • 13.3.2 RECENT FINANCIALS 169
  • 13.3.3 COMPANY SHARE ANALYSIS 170
  • 13.3.4 PRODUCT PORTFOLIO 170
  • 13.3.5 RECENT DEVELOPMENTS 171
  • 13.3.6 SWOT ANALYSIS 172
• 13.4 BD 173
  • 13.4.1 COMPANY SNAPSHOT 173
  • 13.4.2 RECENT FINANCIALS 173
  • 13.4.3 COMPANY SHARE ANALYSIS 174
  • 13.4.4 PRODUCT PORTFOLIO 174
  • 13.4.5 RECENT DEVELOPMENTS 174
  • 13.4.6 SWOT ANALYSIS 175
• 13.5 EPPENDORF AG 176
  • 13.5.1 COMPANY SNAPSHOT 176
  • 13.5.2 REVENUE ANALYSIS 176
  • 13.5.3 COMPANY SHARE ANALYSIS 177
  • 13.5.4 PRODUCT PORTFOLIO 177
  • 13.5.5 RECENT DEVELOPMENTS 179
  • 13.5.6 SWOT ANALYSIS 179
• 13.6 ADVANCED INSTRUMENTS 180
  • 13.6.1 COMPANY SNAPSHOT 180
  • 13.6.2 PRODUCT PORTFOLIO 180
  • 13.6.3 RECENT DEVELOPMENTS 180
• 13.7 BENCHMARK SCIENTIFIC INC. 182
  • 13.7.1 COMPANY SNAPSHOT 182
  • 13.7.2 PRODUCT PORTFOLIO 182
  • 13.7.3 RECENT DEVELOPMENTS 182
• 13.8 BIOSPHERIX LTD. 183
  • 13.8.1 COMPANY SNAPSHOT 183
  • 13.8.2 PRODUCT PORTFOLIO 183
  • 13.8.3 RECENT DEVELOPMENTS 183
• 13.9 BIOTRON HEALTHCARE 185
  • 13.9.1 COMPANY SNAPSHOT 185
  • 13.9.2 PRODUCT PORTFOLIO 185
  • 13.9.3 RECENT DEVELOPMENTS 185
• 13.10 BULLDOG-BIO, INC. 186
  • 13.10.1 COMPANY SNAPSHOT 186
  • 13.10.2 PRODUCT PORTFOLIO 186
• 13.11 CELL CULTURE COMPANY, LLC 188
  • 13.11.1 COMPANY SNAPSHOT 188
  • 13.11.2 PRODUCT PORTFOLIO 188
  • 13.11.3 RECENT DEVELOPMENT 189
• 13.12 CELLGENIX GMBH 190
  • 13.12.1 COMPANY SNAPSHOT 190
  • 13.12.2 PRODUCT PORTFOLIO 190
  • 13.12.3 RECENT DEVELOPMENTS 190
• 13.13 CHEMOMETEC 192
  • 13.13.1 COMPANY SNAPSHOT 192
  • 13.13.2 REVENUE ANALYSIS 192
  • 13.13.3 PRODUCT PORTFOLIO 193
  • 13.13.4 RECENT DEVELOPMENT 193
• 13.14 CORNING INCORPORATED 194
  • 13.14.1 COMPANY SNAPSHOT 194
  • 13.14.2 RECENT FINANCIALS 194
  • 13.14.3 PRODUCT PORTFOLIO 195
  • 13.14.4 RECENT DEVELOPMENTS 196
• 13.15 CYTIVA (SUBSIDIARY OF DANAHER CORPORATION) 197
  • 13.15.1 COMPANY SNAPSHOT 197
  • 13.15.2 REVENUE ANALYSIS 197
  • 13.15.3 PRODUCT PORTFOLIO 198
  • 13.15.4 RECENT DEVELOPMENTS 199
• 13.16 FUJIFILM HOLDINGS AMERICA CORPORATION 201
  • 13.16.1 COMPANY SNAPSHOT 201
  • 13.16.2 REVENUE ANALYSIS 201
  • 13.16.3 PRODUCT PORTFOLIO 202
  • 13.16.4 RECENT DEVELOPMENTS 202
• 13.17 HAMILTON COMPANY 203
  • 13.17.1 COMPANY SNAPSHOT 203
  • 13.17.2 PRODUCT PORTFOLIO 203
  • 13.17.3 RECENT DEVELOPMENTS 203
• 13.18 HITACHI, LTD. 205
  • 13.18.1 COMPANY SNAPSHOT 205
  • 13.18.2 REVENUE ANALYSIS 205
  • 13.18.3 PRODUCT PORTFOLIO 206
  • 13.18.4 RECENT DEVELOPMENTS 206
• 13.19 KAWASAKI HEAVY INDUSTRIES, LTD. 207
  • 13.19.1 COMPANY SNAPSHOT 207
  • 13.19.2 REVENUE ANALYSIS 207
  • 13.19.3 PRODUCT PORTFOLIO 208
  • 13.19.4 RECENT DEVELOPMENTS 208
• 13.20 HIMEDIA LABORATORIES 209
  • 13.20.1 COMPANY SNAPSHOT 209
  • 13.20.2 PRODUCT PORTFOLIO 209
  • 13.20.3 RECENT DEVELOPMENTS 211
• 13.21 NANOENTEK AMERICA INC. (A SUBSIDIARY OF NANOENTEK) 212
  • 13.21.1 COMPANY SNAPSHOT 212
  • 13.21.2 PRODUCT PORTFOLIO 212
  • 13.21.3 RECENT DEVELOPMENTS 213
• 13.22 NEXCELOM BIOSCIENCE LLC. 214
  • 13.22.1 COMPANY SNAPSHOT 214
  • 13.22.2 PRODUCT PORTFOLIO 214
  • 13.22.3 RECENT DEVELOPMENTS 215
• 13.23 PROMOCELL GMBH 216
  • 13.23.1 COMPANY SNAPSHOT 216
  • 13.23.2 PRODUCT PORTFOLIO 216
  • 13.23.3 RECENT DEVELOPMENTS 217
• 13.24 RWD LIFE SCIENCE CO LTD. 218
  • 13.24.1 COMPANY SNAPSHOT 218
  • 13.24.2 PRODUCT PORTFOLIO 218
  • 13.24.3 RECENT DEVELOPMENTS 219
• 13.25 SARTORIUS AG 220
  • 13.25.1 COMPANY SNAPSHOT 220
  • 13.25.2 REVENUE ANALYSIS 220
  • 13.25.3 PRODUCT PORTFOLIO 221
  • 13.25.4 RECENT DEVELOPMENTS 221
• 13.26 SCIENTICA INSTRUMENTATION, INC. 223
  • 13.26.1 COMPANY SNAPSHOT 223
  • 13.26.2 PRODUCT PORTFOLIO 223
  • 13.26.3 RECENT DEVELOPMENTS 223
• 13.27 SHIBUYA CORPORATION 225
  • 13.27.1 COMPANY SNAPSHOT 225
  • 13.27.2 RECENT FINANCIALS 225
  • 13.27.3 PRODUCT PORTFOLIO 226
  • 13.27.4 RECENT DEVELOPMENTS 226
• 13.28 SPHERE FLUIDICS LIMITED 227
  • 13.28.1 COMPANY SNAPSHOT 227
  • 13.28.2 PRODUCT PORTFOLIO 227
  • 13.28.3 RECENT DEVELOPMENTS 227
• 13.29 TECAN TRADING AG 229
  • 13.29.1 COMPANY SNAPSHOT 229
  • 13.29.2 RECENT FINANCIALS 229
  • 13.29.3 PRODUCT PORTFOLIO 230
  • 13.29.4 RECENT DEVELOPMENT 230
• 13.30 THRIVE BIOSCIENCE, INC. 231
  • 13.30.1 COMPANY SNAPSHOT 231
  • 13.30.2 PRODUCT PORTFOLIO 231
  • 13.30.3 RECENT DEVELOPMENTS 231

14 QUESTIONNAIRE 233

15 RELATED REPORTS 237

LIST OF FIGURES

• FIGURE 1 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: SEGMENTATION 27
• FIGURE 2 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: DATA TRIANGULATION 30
• FIGURE 3 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: DROC ANALYSIS 31
• FIGURE 4 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS 32
• FIGURE 5 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: COMPANY RESEARCH ANALYSIS 32
• FIGURE 6 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: INTERVIEW DEMOGRAPHICS 34
• FIGURE 7 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: DBMR MARKET POSITION GRID 35
• FIGURE 8 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: MARKET APPLICATION COVERAGE GRID 36
• FIGURE 9 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: VENDOR SHARE ANALYSIS 37
• FIGURE 10 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: SEGMENTATION 40
• FIGURE 11 WIDE ACCEPTANCE OF CELL CULTURE TECHNIQUES IN VARIOUS APPLICATIONS AND THE GROWING BIOTECHNOLOGY SECTOR ARE EXPECTED TO DRIVE THE ASIA PACIFIC AUTOMATED CELL CULTURES MARKET IN THE FORECAST PERIOD 41
• FIGURE 12 CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC AUTOMATED CELL CULTURES MARKET IN 2022 & 2029 41
• FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA PACIFIC AUTOMATED CELL CULTURES MARKET 45
• FIGURE 14 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY PRODUCT, 2021 55
• FIGURE 15 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY PRODUCT, 2022-2029 (EURO MILLION) 56
• FIGURE 16 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY PRODUCT, CAGR (2022-2029) 56
• FIGURE 17 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY PRODUCT, LIFELINE CURVE 57
• FIGURE 18 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY TYPE, 2021 67
• FIGURE 19 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY TYPE, 2022-2029 (EURO MILLION) 68
• FIGURE 20 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY TYPE, CAGR (2022-2029) 68
• FIGURE 21 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY TYPE, LIFELINE CURVE 69
• FIGURE 22 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY APPLICATION, 2021 72
• FIGURE 23 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY APPLICATION, 2022-2029 (EURO MILLION) 73
• FIGURE 24 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY APPLICATION, CAGR (2022-2029) 73
• FIGURE 25 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY APPLICATION, LIFELINE CURVE 74
• FIGURE 26 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY END USER, 2021 81
• FIGURE 27 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY END USER, 2022-2029 (EURO MILLION) 82
• FIGURE 28 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY END USER, CAGR (2022-2029) 82
• FIGURE 29 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY END USER, LIFELINE CURVE 83
• FIGURE 30 ASIA-PACIFIC AUTOMATED CELL CULTURES MARKET : SNAPSHOT (2021) 88
• FIGURE 31 ASIA-PACIFIC AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2021) 89
• FIGURE 32 ASIA-PACIFIC AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2022 & 2029) 89
• FIGURE 33 ASIA-PACIFIC AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2021 & 2029) 90
• FIGURE 34 ASIA-PACIFIC AUTOMATED CELL CULTURES MARKET : BY PRODUCT (2022-2029) 90
• FIGURE 35 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: COMPANY SHARE 2021 (%) 147